While the role of spinal inhibitory circuits remains speculative, ongoing research is essential to fully elucidate the pathophysiological underpinnings of CASPR2-associated PNH and refine diagnostic and therapeutic approaches. The gene discussed is CNTNAP2; the disease is paroxysmal nocturnal hemoglobinuria.